SPIEF 2021

Genetic technologies in medicine are undergoing a real leap in development. Genome sequencing is widely used in health management programs to detect diseases at an early stage and provide effective therapy. The widespread introduction of cell and gene therapy technologies into clinical practice today opens up unprecedented opportunities for medicine in the fight against diseases that are considered incurable today. At the same time, the issues of the admissibility of interference in the human genome create a huge resonance today, faced with issues of a socio-ethical nature and interference in the evolution of humanity as a whole. Undoubtedly, the development of genetic technologies is a matter of progressive medicine and national biosafety. But there is also no doubt the need to create state mechanisms that protect the rights and freedom of the human person. What achievements for the healthcare sector in the field of diagnostic systems, innovative treatment algorithms, and medicines is the development of genetic technologies driving? What are the reality and prospects of genetic technologies in clinical practice? What kind of innovative genetic research is being carried out in Russia, and what diseases can they help prevent in the near future? What are the prospects for their development in healthcare? What international experience in gene diagnostics and therapy is the most acceptable for Russia today? What are the opportunities and risks of research in the field of human genome editing? What are the prospects for their transfer to practical medicine? What tasks does the Federal Scientific and Technological Program of Genetic Technologies meet?